revenue
Novo Nordisk cuts 1300 jobs in the midst of Trump’s pricing pressures and depreciation of US dollar
November 2, 2018Medical Communications Jobs, Novo Nordisk, Trump, pressure, pricing, revenue
Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …
Shire completes Baxalta takeover
June 3, 2016Medical Communications, Research and Development, Sales and Marketing Baxalta, Shire, deal, merger and acquisition, revenue, sales
UK drugmaker Shire (LSE: SHP) on Friday announced the completion of merger with rare disease specialist Baxalta (NYSE: BXLT). The …
Allergan to buy back $10 billion of stock, Q1 earnings rise
May 11, 2016Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue
Botox-maker Allergan (NYSE: AGN) said it plans to buy back as much as $10 billion in stock after completing the …
Endo shares plunge almost 40% as company cuts FY outlook
May 9, 2016Sales and Marketing Endo International, earnings, outlook, revenue
Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …
Pfizer revenue jumps 20%; ups FY16 outlook
May 4, 2016Research and Development, Sales and Marketing Pfizer, Q1, earnings, results, revenue, sales
US pharma giant Pfizer (NYSE: PFE) reported a 20% jump in first-quarter revenue boosted by performance of its new cancer …
Mylan Q1 revenue up 17%, maintains FY view
May 3, 2016Manufacturing and Production, Sales and Marketing Financial, Mylan, Q1, results, revenue, sales
Pharma firm Mylan NV (Nasdaq: MYL) on Tuesday reported a 17% rise in first-quarter revenue and said it maintains its …
GlaxoSmithKline Q1 earnings up 14% on new product sales
April 27, 2016Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Q1, earnings, results, revenue, sales
GlaxoSmithKline (LSE: GSK) reported a 14% rise in first-quarter earnings driven by demand for new drugs. The UK drug firm …
Baxter hikes 2016 earnings view driven by strong Q1 results
April 27, 2016Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue
Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …
Eli Lilly Q1 earnings miss estimates, ups FY view; shares drop 2%
April 27, 2016Research and Development, Sales and Marketing Eli Lilly, FY, Q1, earnings, revenue, sales
Shares in US drugmaker Eli Lilly (NYSE: LLY) dropped to close down over 2% Tuesday after the company posted first-quarter …
Illumina shares plunge as it cuts Q1 outlook
April 20, 2016Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market
Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …
J&J raises FY outlook, Q1 beats estimates
April 20, 2016Business Services, Research and Development, Sales and Marketing Financial, Johnson & Johnson, Q1, earnings, results, revenue, sales
Healthcare giant Johnson & Johnson (NYSE: JNJ) raised its full-year outlook and posted first-quarter earnings ahead of estimates despite currency headwinds. …
Revenues down at MSD
February 4, 2016Sales and Marketing MSD, financial performance, profits, revenue, sales
MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …
Pfizer revenues down, but above expectations
February 3, 2016Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales
Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
Novartis braces for cuts after mixed 2015 performance
January 28, 2016Sales and Marketing Novartis, financial results, revenue, sales
Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
